Clinical Study of Gefitinib Combined with Anlotinib Hydrochloride in the First-line Treatment of EGFR Mutation Advanced Non-small Cell Lung Cancer

JI Hongbo; WANG Lele; SHANG Di; YIN Shengjie; WANG Xiaoying; SUN Lili; YU Haibo; GAO Zhiyan; MA Xiaoyun; WANG Lei

doi:10.14033/j.cnki.cfmr.2020.28.015

Home>Articles>Clinical Study of Gefitinib Combined with Anlotinib Hydrochloride in the First-line Treatment of EGFR Mutation Advanced Non-small Cell Lung Cancer

DOI: 10.14033/j.cnki.cfmr.2020.28.015

Clinical Study of Gefitinib Combined with Anlotinib Hydrochloride in the First-line Treatment of EGFR Mutation Advanced Non-small Cell Lung Cancer

JI Hongbo

WANG Lele

SHANG Di

YIN Shengjie

WANG Xiaoying

SUN Lili

YU Haibo

GAO Zhiyan

MA Xiaoyun

WANG Lei

Machine-generated Keywords：

Publication Date：2020-10-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：3( 37-39 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2020,18(28)